CSE: UDOC | FRA: L7T | OTC: UDOCF
Investor
Presentation
Click To
Download
Investor Presentation
Click To
Download
News
Alerts
Click To
Sign Up
News Alerts
Click To
Sign Up

Category: News

UniDoc Accesses Physician Network and AI patient intake technology via MediOrbis Agreement

Top tier specialty physicians, services, and features with 24/7 access VANCOUVER, British Columbia, December 05, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce that it has entered into a reseller agreement (the “Agreement”) with MediOrbis, LLC (“MediOrbis”) to […]

UniDoc Health Announces Extension of Warrants

VANCOUVER, British Columbia, October 04, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, announces the Company is extending 1,376,050 of its share purchase warrants (the “Warrants”). The Warrants were issued on October 25, 2021 in connection with the conversion of 2,752,100 special […]

UniDoc Enters Joint Marketing and Services Agreement

Virtual Care Solutions Model to be marketed in Caribbean VANCOUVER, British Columbia, September 15, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce that it has entered into a joint agreement (the “Agreement”) with EGS Health Inc. (“EGS” or […]

UniDoc Signs Definitive Agreement to Provide eHealth Services to FANA

Second Definitive Agreement Signed for North America VANCOUVER, British Columbia, September 12, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce that it has entered into a definitive master equipment deployment and services agreement (the “Agreement”) with the Federation […]

UniDoc Introduces Artificial Intelligence (AI) Integration

AI software adds powerful diagnostic monitoring and assessment features and benefits. VANCOUVER, British Columbia, July 17, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTC: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce the adoption of artificial intelligence (AI) technology into its innovative eHealth virtual clinic kiosk […]

UniDoc Receives European Trademark Approval

VANCOUVER, British Columbia, June 26, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce the grants of European Union Intellectual Property Office registration number 1704468. The trademark includes the H3 Health Cube logo and wording. CEO of UniDoc, Antonio […]

UniDoc Partner Receives Purchase Order

H3 Health Cubes to be supplied to Italian Company VANCOUVER, British Columbia, June 19, 2023 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce that partner Hewlett Packard (“HP”) has received a purchase order to supply the UniDoc H3 Health […]

UniDoc to Exhibit at Medica in Germany

Company to Present Solutions Alongside Hewlett-Packard in Hall 16, Booth D21-6 VANCOUVER, British Columbia, November 09, 2022 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce it will be exhibiting at the world’s largest event for the medical sector in […]

UniDoc Signs Definitive Agreement to Provide Telehealth Services in South Africa

Fourth Definitive Agreement Signed for Africa VANCOUVER, British Columbia, September 27, 2022 — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce that it has entered into a definitive master equipment deployment and services agreement (the “Agreement”) with Mbelem (Pty) Ltd. […]

UniDoc Successfully Concludes Pilot Trials with OnPharm-United

–OnPharm-United requests to move project to contract VANCOUVER, BC, August 31, 2022 (GLOBE NEWSWIRE) – UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to announce it has successfully concluded a series of pilot trials with OnPharm-United, a network of independent pharmacies in […]

CSE: UDOC | FRA: L7T | OTC: UDOCF
Investor Presentation

Subscribe to News Alerts

By submitting the form, you agree to receive communications from UniDoc Health.

"*" indicates required fields

Consent*

UniDoc Health Corp. © 2023. All rights reserved.

Sign Up For News Alerts

Enter your details below and we will add you to our News Alerts list.

Consent(Required)

Austin Thornberry

Director

Mr. Thornberry is a seasoned finance professional with a background in advising new companies in the venture capital market. He brings extensive experience working with high-growth companies across numerous industries through his past work in the technology and innovation banking group at the Bank of Montreal and in the financial services arm of Ernst & Young advising on multiple capital markets transactions. Mr. Thornberry has split his time working in Toronto, Ont., and Vancouver, B.C. He obtained his bachelor of commerce at McGill University and has held the CPA, CA, designation since 2019.

Matt Chatterton

DIRECTOR

Mr. Chatterton brings over 18 years of experience in development and execution of complex projects. His  expertise includes project management, facility management, logistics, and supply side processes and  procedures at a number of operations in Canada and internationally. He has  been involved in the public markets for the last three years managing IPO processes and transitioning  businesses to post listing operations. Mr. Chatterton is a Professional Engineer and graduate of  Canada’s Queens University with a Bachelor’s degree in Engineering Chemistry (2001) and Master’s degree in Chemical Process Engineering (2003).

Sina Pirooz

Director

Mr. Chatterton brings over 18 years of experience in development and execution of complex projects. His  expertise includes project management, facility management, logistics, and supply side processes and  procedures at a number of operations in Canada and internationally. He has  been involved in the public markets for the last three years managing IPO processes and transitioning  businesses to post listing operations. Mr. Chatterton is a Professional Engineer and graduate of  Canada’s Queens University with a Bachelor’s degree in Engineering Chemistry (2001) and Master’s degree in Chemical Process Engineering (2003).

Dr. Sazzad Hossain, PhD

Chief Scientific Officer

He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.

Jacob Moshinsky

Chief Operating Officer

Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.

Antonio Baldassarre

CEO, President and Director

Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels.

Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value.

Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.

Franco Staino

DIRECTOR

Mr. Franco Staino is a business professional with over 40 years experience in the pharmaceutical industry. Mr. Staino has significant experience in drug safety, traceability and anti-counterfeiting measures and has designed and implemented programs for the Italy National Health Service, the Ministry of Health and the Polygraphic Institute and State Mint.

Mr. Staino currently holds multiple positions including being the control representative of Carlucci a leading company engaged in the production of self-adhesive labels for consumer goods with high specialization for the pharmaceutical sector, and President of the Board of Directors of Topharmacia, a company that deals with the integral management of pharmacies throughout Italy in order to improve their ability to provide social and commercial services, to connect industrial marketing policy to that of the pharmacy, to offer tools in able to guarantee the financial balance of the companies involved.